2023 Q4 Form 10-Q Financial Statement

#000175789823000013 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $1.396B $1.342B $1.201B
YoY Change 14.77% 11.82% 0.3%
Cost Of Revenue $793.1M $748.8M $668.2M
YoY Change 14.19% 12.07% -6.76%
Gross Profit $602.6M $593.5M $532.3M
YoY Change 15.55% 11.5% 10.82%
Gross Profit Margin 43.18% 44.22% 44.34%
Selling, General & Admin $360.5M $380.7M $323.2M
YoY Change 18.15% 17.78% -6.27%
% of Gross Profit 59.83% 64.13% 60.71%
Research & Development $25.91M $27.04M $24.93M
YoY Change 1.56% 8.49% 32.37%
% of Gross Profit 4.3% 4.56% 4.68%
Depreciation & Amortization $140.6M $152.3M $133.9M
YoY Change 1.92% 13.76% 13.42%
% of Gross Profit 23.33% 25.66% 25.15%
Operating Expenses $386.4M $407.7M $838.8M
YoY Change 16.86% -51.4% 130.53%
Operating Profit $216.2M $185.9M -$306.4M
YoY Change 13.29% -160.66% -363.01%
Interest Expense $38.95M $36.94M $26.12M
YoY Change 36.37% 41.41% 13.4%
% of Operating Profit 18.02% 19.88%
Other Income/Expense, Net -$36.87M -$35.70M -$26.65M
YoY Change 21.01% 33.99% -0.93%
Pretax Income $179.3M $150.2M -$333.1M
YoY Change 11.82% -145.08% -471.69%
Income Tax $38.34M $33.81M -$17.83M
% Of Pretax Income 21.39% 22.52%
Net Earnings $140.7M $115.3M -$315.3M
YoY Change 13.66% -136.58% -551.63%
Net Earnings / Revenue 10.08% 8.59% -26.26%
Basic Earnings Per Share $1.42 $1.17 -$3.15
Diluted Earnings Per Share $1.42 $1.16 -$3.15
COMMON SHARES
Basic Shares Outstanding 98.80M shares 98.78M shares 100.0M shares
Diluted Shares Outstanding 99.35M shares 99.41M shares 99.97M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $195.6M $214.0M $258.3M
YoY Change -24.59% -17.14% -32.66%
Cash & Equivalents $195.6M $213.8M $258.3M
Short-Term Investments
Other Short-Term Assets $203.7M $199.0M $205.0M
YoY Change 1.79% -2.92% 5.34%
Inventory $855.6M $821.1M $644.9M
Prepaid Expenses
Receivables $964.0M $940.3M $780.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.219B $2.174B $1.888B
YoY Change 12.26% 15.13% -0.86%
LONG-TERM ASSETS
Property, Plant & Equipment $1.844B $1.744B $1.572B
YoY Change 10.37% 10.9% 4.05%
Goodwill $4.112B $4.040B $3.705B
YoY Change 6.71% 9.04% -27.81%
Intangibles $2.987B $3.058B $3.077B
YoY Change -1.46% -0.64% 4.17%
Long-Term Investments
YoY Change
Other Assets $77.34M $72.63M $72.23M
YoY Change -3.76% 0.55% 44.12%
Total Long-Term Assets $9.216B $9.107B $8.601B
YoY Change 4.45% 5.87% -12.66%
TOTAL ASSETS
Total Short-Term Assets $2.219B $2.174B $1.888B
Total Long-Term Assets $9.216B $9.107B $8.601B
Total Assets $11.44B $11.28B $10.49B
YoY Change 5.88% 7.54% -10.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $276.7M $293.6M $233.3M
YoY Change 14.12% 25.85% 6.41%
Accrued Expenses $318.1M $306.7M $304.0M
YoY Change 4.97% 0.86% -1.59%
Deferred Revenue
YoY Change
Short-Term Debt $78.44M $70.94M $151.0M
YoY Change 30.73% -53.02% 590.29%
Long-Term Debt Due $78.44M $71.00M $151.0M
YoY Change 30.73% -52.98% 590.29%
Total Short-Term Liabilities $913.7M $873.1M $872.8M
YoY Change 14.72% 0.03% 11.09%
LONG-TERM LIABILITIES
Long-Term Debt $3.231B $3.366B $2.874B
YoY Change 7.65% 17.13% -16.0%
Other Long-Term Liabilities $78.39M $76.55M $75.90M
YoY Change 7.76% 0.85% -9.2%
Total Long-Term Liabilities $3.309B $3.443B $2.950B
YoY Change 7.65% 16.71% -15.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $913.7M $873.1M $872.8M
Total Long-Term Liabilities $3.309B $3.443B $2.950B
Total Liabilities $5.007B $5.091B $4.676B
YoY Change 5.38% 8.88% -10.2%
SHAREHOLDERS EQUITY
Retained Earnings $2.134B $2.046B $1.695B
YoY Change 20.5% 20.7% -10.46%
Common Stock $4.534B $4.519B $4.705B
YoY Change -2.1% -3.96% -0.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.415B $6.178B $5.802B
YoY Change
Total Liabilities & Shareholders Equity $11.44B $11.28B $10.49B
YoY Change 5.88% 7.54% -10.75%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $140.7M $115.3M -$315.3M
YoY Change 13.66% -136.58% -551.63%
Depreciation, Depletion And Amortization $140.6M $152.3M $133.9M
YoY Change 1.92% 13.76% 13.42%
Cash From Operating Activities $291.3M $146.1M $103.8M
YoY Change 41.68% 40.72% -39.4%
INVESTING ACTIVITIES
Capital Expenditures $118.9M $83.30M -$82.77M
YoY Change 29.53% -200.64% 7.53%
Acquisitions
YoY Change
Other Investing Activities -$25.00K -$522.9M -$15.16M
YoY Change -99.62% 3349.89% -9015.88%
Cash From Investing Activities -$119.0M -$606.2M -$97.93M
YoY Change 20.88% 519.05% 27.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -198.0M 470.2M -44.95M
YoY Change 64.45% -1146.1% -81.2%
NET CHANGE
Cash From Operating Activities 291.3M 146.1M 103.8M
Cash From Investing Activities -119.0M -606.2M -97.93M
Cash From Financing Activities -198.0M 470.2M -44.95M
Net Change In Cash -25.70M 10.10M -39.05M
YoY Change 94.12% -125.86% -72.99%
FREE CASH FLOW
Cash From Operating Activities $291.3M $146.1M $103.8M
Capital Expenditures $118.9M $83.30M -$82.77M
Free Cash Flow $172.3M $62.80M $186.6M
YoY Change 51.49% -66.34% -24.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.52
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.90
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.99
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
30000000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
126875000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
391022000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
99111000 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
177000 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
153000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9213000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
69922000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
97795000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
89981000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2740000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1458000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
256577000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-186362000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5568000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-31927000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5400000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-90061000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
208357000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
348320000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213757000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
258259000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6178372000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
116346000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-75876000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
489000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22201000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.52
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
51368000 usd
CY2023Q3 ste Increase Decrease In Noncontrolling Interests Other
IncreaseDecreaseInNoncontrollingInterestsOther
-18000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6189168000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6087172000 usd
us-gaap Profit Loss
ProfitLoss
240136000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-66025000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9213000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
35035000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.99
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
97795000 usd
ste Increase Decrease In Noncontrolling Interests Other
IncreaseDecreaseInNoncontrollingInterestsOther
-142000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6189168000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6419128000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-315231000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-209775000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
45243000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11785000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.47
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
46973000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make certain estimates and assumptions when preparing financial statements according to U.S. GAAP that affect the reported amounts of assets and liabilities at the financial statement dates and the reported amounts of revenues and expenses during the periods presented. These estimates and assumptions involve judgments with respect to many factors that are difficult to predict and are beyond our control. Actual results could be materially different from these estimates. We revise the estimates and assumptions as new information becomes available. This means that operating results for the three and six month periods ended September 30, 2023 are not necessarily indicative of results that may be expected for future quarters or for the full fiscal year ending March 31, 2024.</span></div>
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
64241000 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
67218000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1579938000 usd
ste Asset Acquisition Tax Deductible Goodwill Expected
AssetAcquisitionTaxDeductibleGoodwillExpected
60000000 usd
CY2023Q1 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
31096000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14038000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13683000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
507000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
543000 usd
CY2023Q3 ste Accrued Interest
AccruedInterest
11657000 usd
CY2023Q1 ste Accrued Interest
AccruedInterest
9243000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
57652000 usd
CY2022Q3 ste Deferred Consideration
DeferredConsideration
6700000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
16013000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
18722000 usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3844000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
13676000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
283914000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
239081000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
109827000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
97756000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
483190000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
404238000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
55802000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
45582000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
821129000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
695493000 usd
CY2023Q3 us-gaap Land
Land
86804000 usd
CY2023Q1 us-gaap Land
Land
84313000 usd
CY2023Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
735544000 usd
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
691933000 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1065048000 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
994188000 usd
CY2023Q3 ste Capitalized Computer Hardware Software Gross
CapitalizedComputerHardwareSoftwareGross
257002000 usd
CY2023Q1 ste Capitalized Computer Hardware Software Gross
CapitalizedComputerHardwareSoftwareGross
247873000 usd
CY2023Q3 us-gaap Materials Supplies And Other
MaterialsSuppliesAndOther
641750000 usd
CY2023Q1 us-gaap Materials Supplies And Other
MaterialsSuppliesAndOther
637920000 usd
CY2023Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
467127000 usd
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
478316000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3253275000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3134543000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1509417000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1429031000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1743858000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1705512000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
87611000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
306664000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
317817000 usd
CY2023Q3 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
22171000 usd
CY2023Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
22171000 usd
CY2023Q3 us-gaap Other Postretirement Benefits Payable Noncurrent
OtherPostretirementBenefitsPayableNoncurrent
5870000 usd
CY2023Q1 us-gaap Other Postretirement Benefits Payable Noncurrent
OtherPostretirementBenefitsPayableNoncurrent
6070000 usd
CY2023Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
2989000 usd
CY2023Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
2876000 usd
CY2023Q3 ste Term Loan Current Portion
TermLoanCurrentPortion
34375000 usd
CY2023Q1 ste Term Loan Current Portion
TermLoanCurrentPortion
27500000 usd
CY2023Q3 ste Delayed Draw Term Loan Current Portion
DelayedDrawTermLoanCurrentPortion
36563000 usd
CY2023Q1 ste Delayed Draw Term Loan Current Portion
DelayedDrawTermLoanCurrentPortion
32500000 usd
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
70938000 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
60000000 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
691966000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
301672000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19325000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
21444000 usd
CY2023Q3 ste Term Loan Long Term Portion
TermLoanLongTermPortion
24375000 usd
CY2023Q1 ste Term Loan Long Term Portion
TermLoanLongTermPortion
45000000 usd
CY2023Q3 ste Delayed Draw Term Loan Long Term Portion
DelayedDrawTermLoanLongTermPortion
572812000 usd
CY2023Q1 ste Delayed Draw Term Loan Long Term Portion
DelayedDrawTermLoanLongTermPortion
593125000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
3366241000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
3018655000 usd
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
3437179000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
3078655000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
50149000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
48565000 usd
CY2023Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
14152000 usd
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
11080000 usd
CY2023Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
43486000 usd
CY2023Q1 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
33605000 usd
CY2023Q3 us-gaap Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
24729000 usd
CY2023Q1 us-gaap Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
29257000 usd
CY2023Q3 us-gaap Other Postretirement Benefits Payable Current And Noncurrent
OtherPostretirementBenefitsPayableCurrentAndNoncurrent
1121000 usd
CY2023Q1 us-gaap Other Postretirement Benefits Payable Current And Noncurrent
OtherPostretirementBenefitsPayableCurrentAndNoncurrent
1121000 usd
CY2023Q3 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent
1885000 usd
CY2023Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent
2014000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
135522000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
125642000 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
92947000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
92283000 usd
CY2023Q3 ste Serviceliabilities
Serviceliabilities
81533000 usd
CY2023Q1 ste Serviceliabilities
Serviceliabilities
72033000 usd
CY2023Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
13233000 usd
CY2023Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
11325000 usd
CY2023Q3 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
35097000 usd
CY2023Q3 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
1179000 usd
CY2023Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
1153000 usd
CY2023Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
10103000 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
10082000 usd
CY2023Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
12640000 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
12588000 usd
CY2023Q3 ste Longtermliabilitiesother
Longtermliabilitiesother
21595000 usd
CY2023Q1 ste Longtermliabilitiesother
Longtermliabilitiesother
21197000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76547000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76137000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.225
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.054
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.221
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.032
us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
12000000 usd
ste Income Tax Examination Amount Of Loss Paid
IncomeTaxExaminationAmountOfLossPaid
11600000 usd
CY2023Q3 ste Uncertain Tax Liability Resulting From Irs Notice
UncertainTaxLiabilityResultingFromIRSNotice
50000000 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. Commitments and Contingencies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, and will likely continue to be, involved in a number of legal proceedings, government investigations, and claims, which we believe generally arise in the course of our business, given our size, history, complexity, and the nature of our business, products, Customers, regulatory environment, and industries in which we participate. These legal proceedings, investigations and claims generally involve a variety of legal theories and allegations, including, without limitation, personal injury (e.g., slip and falls, burns, vehicle accidents), product liability or regulation (e.g., based on product operation or claimed malfunction, failure to warn, failure to meet specification, or failure to comply with regulatory requirements), product exposure (e.g., claimed exposure to chemicals, gases, asbestos, contaminants, radiation), property damage (e.g., claimed damage due to leaking equipment, fire, vehicles, chemicals), commercial claims (e.g., breach of contract, economic loss, warranty, misrepresentation), financial (e.g., taxes, reporting), employment (e.g., wrongful termination, discrimination, benefits matters), and other claims for damage and relief.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have adequately reserved for our current litigation and claims that are probable and estimable, and further believe that the ultimate outcome of these pending lawsuits and claims will not have a material adverse effect on our consolidated financial position or results of operations taken as a whole. Due to their inherent uncertainty, however, there can be no assurance of the ultimate outcome or effect of current or future litigation, investigations, claims or other proceedings (including without limitation the matters discussed below). For certain types of claims, we presently maintain insurance coverage for personal injury and property damage and other liability coverages in amounts and with deductibles that we believe are prudent, but there can be no assurance that these coverages will be applicable or adequate to cover adverse outcomes of claims or legal proceedings against us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Civil, criminal, regulatory or other proceedings involving our products or services could possibly result in judgments, settlements or administrative or judicial decrees requiring us, among other actions, to pay damages or fines or effect recalls, or be subject to other governmental, Customer or other third party claims or remedies, which could materially effect our business, performance, prospects, value, financial condition, and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding these matters, see the following portions of our Annual Report on Form 10-K for the year ended March 31, 2023, which was filed with the SEC on May 26, 2023, Item 1 titled "Business - Information with respect to our Business in General - Government Regulation" and the "Risk Factors" in Item 1A titled "Product and service related regulations and claims."</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, STERIS is also involved in legal proceedings as a plaintiff involving contract, patent protection, and other claims asserted by us. Gains, if any, from these proceedings are recognized when they are realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation from United States federal, state and local, and foreign jurisdictions. Tax positions are settled primarily through the completion of audits within each individual jurisdiction or the closing of statutes of limitation. Changes in applicable tax law or other events may also require us to revise past estimates. We describe income taxes further in Note 7 to our consolidated financial statements titled, “Income Taxes” in this Quarterly Report on Form 10-Q.</span></div>
CY2023Q3 us-gaap Revenues
Revenues
1342360000 usd
CY2022Q3 us-gaap Revenues
Revenues
1200517000 usd
us-gaap Revenues
Revenues
2626902000 usd
us-gaap Revenues
Revenues
2357008000 usd
CY2023Q3 ste Amortizationandimpairmentofacquiredintangibleassets
Amortizationandimpairmentofacquiredintangibleassets
99011000 usd
CY2022Q3 ste Amortizationandimpairmentofacquiredintangibleassets
Amortizationandimpairmentofacquiredintangibleassets
93859000 usd
ste Amortizationandimpairmentofacquiredintangibleassets
Amortizationandimpairmentofacquiredintangibleassets
192936000 usd
ste Amortizationandimpairmentofacquiredintangibleassets
Amortizationandimpairmentofacquiredintangibleassets
187786000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
16013000 usd
CY2022Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3844000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
18722000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
13676000 usd
CY2023Q3 ste Redomiciliaton And Tax Restructuring Costs Ax Restructuring
RedomiciliatonAndTaxRestructuringCostsAxRestructuring
0 usd
CY2022Q3 ste Redomiciliaton And Tax Restructuring Costs Ax Restructuring
RedomiciliatonAndTaxRestructuringCostsAxRestructuring
77000 usd
ste Redomiciliaton And Tax Restructuring Costs Ax Restructuring
RedomiciliatonAndTaxRestructuringCostsAxRestructuring
9000 usd
ste Redomiciliaton And Tax Restructuring Costs Ax Restructuring
RedomiciliatonAndTaxRestructuringCostsAxRestructuring
251000 usd
CY2023Q3 ste Lossgainonfairvaluecontingentconsiderationadjustments
Lossgainonfairvaluecontingentconsiderationadjustments
0 usd
CY2022Q3 ste Lossgainonfairvaluecontingentconsiderationadjustments
Lossgainonfairvaluecontingentconsiderationadjustments
0 usd
ste Lossgainonfairvaluecontingentconsiderationadjustments
Lossgainonfairvaluecontingentconsiderationadjustments
0 usd
ste Lossgainonfairvaluecontingentconsiderationadjustments
Lossgainonfairvaluecontingentconsiderationadjustments
-3100000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-899000 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-4777000 usd
CY2023Q3 ste Amortizationofinventoryandpropertystepuptofairvalue
Amortizationofinventoryandpropertystepuptofairvalue
1138000 usd
CY2022Q3 ste Amortizationofinventoryandpropertystepuptofairvalue
Amortizationofinventoryandpropertystepuptofairvalue
2452000 usd
ste Amortizationofinventoryandpropertystepuptofairvalue
Amortizationofinventoryandpropertystepuptofairvalue
2981000 usd
ste Amortizationofinventoryandpropertystepuptofairvalue
Amortizationofinventoryandpropertystepuptofairvalue
4089000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
-23000 usd
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
62000 usd
us-gaap Restructuring Charges
RestructuringCharges
-4000 usd
us-gaap Restructuring Charges
RestructuringCharges
89000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
490565000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
490565000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
185857000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-306415000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
374739000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-148020000 usd
CY2023Q3 us-gaap Revenues
Revenues
1342360000 usd
CY2022Q3 us-gaap Revenues
Revenues
1200517000 usd
us-gaap Revenues
Revenues
2626902000 usd
us-gaap Revenues
Revenues
2357008000 usd
CY2023Q3 us-gaap Revenues
Revenues
1342360000 usd
CY2022Q3 us-gaap Revenues
Revenues
1200517000 usd
us-gaap Revenues
Revenues
2626902000 usd
us-gaap Revenues
Revenues
2357008000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98785000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99969000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98747000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100025000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
621000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
576000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99406000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99969000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99323000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100025000 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 ste Deferred Ordinary Shares
DeferredOrdinaryShares
25000 shares
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
292487 shares
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
59561000 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
57161 shares
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9213000 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
64436 shares
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11769000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2367257 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0359
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0244
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0108
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0080
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.2792
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.2449
ste Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0222
ste Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0254
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-310859000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-320710000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-75601000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-65390000 usd
CY2023Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-275000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-635000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-75876000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1749729 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
154.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
253946 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
220.24
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
41597 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
60.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2128 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
200.46
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1959950 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
165.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
114142000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1338836 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
138.12
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
110765000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
606045 shares
CY2023Q3 ste Common Stock Fair Market Value Per Share
CommonStockFairMarketValuePerShare
219.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6467000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4553000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2740000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1458000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
54.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
50.72
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
83007000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-66025000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-386735000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-386735000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13683000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
8205000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
7850000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
14038000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
65000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
138000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-643000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-1727000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
15678000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
16445000 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-209808000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-388093000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-247000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-388340000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-598148000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3879219000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
202399000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-4281000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-37092000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
4040245000 usd
CY2022Q1 us-gaap Goodwill
Goodwill
4404343000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1286000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
22088000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
490565000 usd
us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
2358000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-229654000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
3705140000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
490565000 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001757898-23-000013-index-headers.html Edgar Link pending
0001757898-23-000013-index.html Edgar Link pending
0001757898-23-000013.txt Edgar Link pending
0001757898-23-000013-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ste-20230930.htm Edgar Link pending
ste-20230930.xsd Edgar Link pending
ste9302023ex101.htm Edgar Link pending
ste9302023ex151.htm Edgar Link pending
ste9302023ex311.htm Edgar Link pending
ste9302023ex312.htm Edgar Link pending
ste9302023ex321.htm Edgar Link pending
ste-20230930_cal.xml Edgar Link unprocessable
ste-20230930_def.xml Edgar Link unprocessable
ste-20230930_lab.xml Edgar Link unprocessable
ste-20230930_pre.xml Edgar Link unprocessable
ste-20230930_htm.xml Edgar Link completed